Kirti Kalgutkar Kalgutkar

Business Analyst

Meril Life Sciences Pvt. Ltd.

Jun 2024 - Present

Developed growth strategies for four major products across Brazil, Colombia, Germany and Saudi Arabia, along with India’s trauma business. Collaborated with country managers and converted market, competitor and sales insights into executive reports and dashboards for promoters and senior management. Mapped market opportunities across 27 existing and upcoming healthcare verticals through primary and secondary research. Transformed findings into interactive dashboards and executive reports to support senior management’s expansion decisions. Built the end-to-end business model and GTM strategy, including market assessment, FY 2026–27 penetration planning and a three-year forecast. Analysed 10+ markets and developed business models for APOC3 and PCSK9 to support commercial and investment decisions. Conducted market mapping and competitor financial analysis across 150 dental products in domestic and international markets. Developed a five-year business plan and GTM model, and presented key findings during the division’s internal soft launch. Conducted market analysis of the Indian Diabetes Device and Gastric Balloon markets, including competitor product benchmarking and a market-assumption model, to identify gaps and position the company's offering as the market's only complete solution. Assessed business potential in the Russian market across Women’s Health, Sleep Apnoea, Urology, Disinfectants, AI-FFR and Gastroenterology, consolidating findings into a market-opportunity report for new-vertical evaluation. Led a cost-optimization initiative that reduced travel policy violations by 23%. Built a standalone, AI-assisted website for the internal team as a quick-fix tool to maximize use of tied-up corporate hotel rates.